Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Non-Current Assets (2016 - 2025)

Healthcare Services (HCSG) has disclosed Non-Current Assets for 17 consecutive years, with $223.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 1.78% to $223.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $987.7 million, a 10.15% increase, with the full-year FY2024 number at $246.1 million, up 12.41% from a year prior.
  • Non-Current Assets was $223.7 million for Q3 2025 at Healthcare Services, down from $269.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $269.9 million in Q2 2025 to a low of $209.0 million in Q1 2023.
  • A 5-year average of $225.5 million and a median of $223.5 million in 2024 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: dropped 9.12% in 2022, then rose 19.17% in 2025.
  • Healthcare Services' Non-Current Assets stood at $233.5 million in 2021, then dropped by 9.12% to $212.2 million in 2022, then increased by 3.18% to $219.0 million in 2023, then grew by 12.41% to $246.1 million in 2024, then fell by 9.12% to $223.7 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Non-Current Assets are $223.7 million (Q3 2025), $269.9 million (Q2 2025), and $248.0 million (Q1 2025).